feed,title,long_url,short_url
Benzinga,Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer,https://benzinga.com/general/biotech/22/01/25107322/seagens-sea-cd40-combo-regime-shows-preliminary-antitumor-activity-in-pancreatic-cancer,https://j.mp/3GKV7E6
Benzinga,Morgan Stanley Bumps Up Alphabet Price By 7.2%,https://benzinga.com/analyst-ratings/analyst-color/22/01/25108333/morgan-stanley-bumps-up-alphabet-price-by-7-2,https://j.mp/3KBpVtB
Benzinga,Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease,https://benzinga.com/general/biotech/22/01/25108209/second-dupixent-phase-3-trial-confirms-significant-improvements-in-inflammatory-skin-disease,https://j.mp/3fBGtDh
